SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001477932-21-007301
Filing Date
2021-10-14
Accepted
2021-10-14 17:00:14
Documents
2
Period of Report
2021-10-10
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K ipix_8k.htm 8-K 16860
2 2016 EQUITY INCENTIVE PLAN, AS AMENDED ipix_ex101.htm EX-10.1 6648
  Complete submission text file 0001477932-21-007301.txt   24907
Mailing Address 301 EDGEWATER PLACE SUITE 100 WAKEFIELD MA 01880
Business Address 301 EDGEWATER PLACE SUITE 100 WAKEFIELD MA 01880 978-921-4125
Innovation Pharmaceuticals Inc. (Filer) CIK: 0001355250 (see all company filings)

IRS No.: 300565645 | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-37357 | Film No.: 211323840
SIC: 2834 Pharmaceutical Preparations